Meet Liz O’Day, CEO of Olaris Therapeutics, a precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.
Related insights
Insight
10 Predictions for 2025
Insight
Copernic Catalysts – Why We Invested
Insight
Why We Invested – Phaseshift Technologies
Insight
Welcome Marjan Majid!
Insight
Why We Invested – Haloo
Insight
Why We Invested – BioIntelligence
Insight
Ten AI Reflections & Predictions
Insight
Innospark Ventures Technologist in Residence Program – Welcoming Kevin Dunnell
Insight
Why We Invested – Via Scientfic
Insight